U.S. Markets close in 3 hrs 17 mins

Genomic Health, Inc. (GHDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.0700-0.1500 (-0.4515%)
As of 12:40PM EDT. Market open.
People also watch
LMNXFMIQGENACORSGEN
Full screen
Previous Close33.2200
Open33.4600
Bid33.0700 x 100
Ask33.1800 x 200
Day's Range32.9300 - 33.4600
52 Week Range25.6600 - 33.9700
Volume36,966
Avg. Volume115,834
Market Cap1.14B
Beta0.68
PE Ratio (TTM)-131.75
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube22 days ago

    ETFs with exposure to Genomic Health, Inc. : June 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Genomic Health, Inc. Here are 5 ETFs with the largest exposure to GHDX-US. Comparing the performance and risk of Genomic Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Genomic Health Cancer Tests Strong, Operating Expenses a Woe
    Zackslast month

    Genomic Health Cancer Tests Strong, Operating Expenses a Woe

    On Jun 19, we issued an updated research report on Redwood City, CA-based Genomic Health Inc (GHDX), a global cancer research company with a focus on advanced molecular diagnostics.

  • Genomic Health, Inc. :GHDX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cubelast month

    Genomic Health, Inc. :GHDX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Genomic Health, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Genomic Health, Inc. – Quest Diagnostics Incorporated, Trovagene, Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Foundation Medicine, Inc., Biocept, Inc., QIAGEN NV, NeoGenomics, Inc. and Exact ... Read more (Read more...)